103 related articles for article (PubMed ID: 10216470)
1. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A; Häfer R; Zintl F; Volm M
Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
[TBL] [Abstract][Full Text] [Related]
2. [Expression of cyclin D1 mRNA in acute leukemia patients and its clinical implication].
Li H; Wang Y; Lou F
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):357-8. PubMed ID: 11721432
[TBL] [Abstract][Full Text] [Related]
3. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of cyclin B1 expression in adult acute leukemia patients].
Ma WD; Xu SR; Guo XN; Jia JS; Xue F
Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):523-6. PubMed ID: 14690581
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
6. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia.
Stachel D; Albert M; Meilbeck R; Paulides M; Schmid I
Oncol Rep; 2007 Jan; 17(1):147-52. PubMed ID: 17143492
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL
Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
Tsai T; Davalath S; Rankin C; Radich JP; Head D; Appelbaum FR; Boldt DH
Leukemia; 1996 Dec; 10(12):1901-10. PubMed ID: 8946929
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cyclin A in adult patients with acute leukemia].
Ma J; Xu SR; Jia JS; Ma WD; Wang Y; Liu XJ; Lai YR; Lu YY
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):556-60. PubMed ID: 12887743
[TBL] [Abstract][Full Text] [Related]
10. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
Gao J; Yuan LX; Sun L; Li XX; Liao QK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract][Full Text] [Related]
13. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
Wu S; Gessner R; Taube T; von Stackelberg A; Henze G; Seeger K
J Clin Oncol; 2005 May; 23(13):3038-42. PubMed ID: 15860861
[TBL] [Abstract][Full Text] [Related]
16. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
18. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
[TBL] [Abstract][Full Text] [Related]
19. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract][Full Text] [Related]
20. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
